|
|
Article: Intron-A/Aldara combination therapy for BCC.(Basal cell carcinoma)(SKIN CANCER)(Drug overview)(Brief article)
- Article from:
- Journal of Drugs in Dermatology
- Article date:
- February 1, 2008
CopyrightCOPYRIGHT 2008 Journal of Drugs in Dermatology, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Sponsored by: The University of Texas Health Science Center, Houston. The purpose of this study is to see if BCC excluding the scalp and face can be treated successfully with a combination therapy of Intron[R]-A and Aldara[R].
Condition Intervention ...